Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

Clinical trial NCT02284529 · COMPLETED

Trial details

NCT number: NCT02284529
Sponsor: Sinphar Pharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Stage-Ⅱ Colorectal Cancer

Start date: 2012-10-01
Primary completion: 2014-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.